Alibaba Health Information Technology Limited (ALBBY)
USD 8.67
(0.0%)
USD 8.67
(0.0%)
| Breakdown | 2024 | 2024 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 27.02 Billion | 27.02 Billion | 20.57 Billion | 15.51 Billion | 9.59 Billion | 5.09 Billion |
| Cost of Revenue | 21.13 Billion | 21.13 Billion | 16.46 Billion | 11.9 Billion | 7.36 Billion | 3.76 Billion |
| Gross Profit | 5.89 Billion | 5.89 Billion | 4.1 Billion | 3.61 Billion | 2.23 Billion | 1.33 Billion |
| Operating Expenses | 5.17 Billion | 5.17 Billion | 5.12 Billion | 3.5 Billion | 2.27 Billion | 1.42 Billion |
| Selling, General and Administrative Expenses | 2.13 Billion | 2.13 Billion | 2.37 Billion | 1.51 Billion | 942.69 Million | 635.85 Million |
| Research and Development Expenses | 705.38 Million | 705.38 Million | 728.82 Million | 423.63 Million | 252.84 Million | 219.01 Million |
| Other Expenses | -359.36 Million | 3.05 Billion | 18.89 Million | -5.42 Million | -14.42 Million | 6.96 Million |
| Cost and Expenses | 26.3 Billion | 26.3 Billion | 21.59 Billion | 15.4 Billion | 9.63 Billion | 5.18 Billion |
| Operating Income | 872.4 Million | 872.4 Million | -792.29 Million | 266.18 Million | -32.52 Million | -62.95 Million |
| Interest Expense | 5.96 Million | 5.96 Million | 3.81 Million | 2.44 Million | 21.96 Million | 27.96 Million |
| Income Tax Expense | 56.26 Million | 56.26 Million | 13.42 Million | 58.53 Million | 24.79 Million | 30.93 Million |
| Earnings before Tax | 939.39 Million | 939.39 Million | -252.51 Million | 401.21 Million | 9.09 Million | -60.83 Million |
| Net Income | 883.47 Million | 883.47 Million | -265.55 Million | 348.58 Million | -6.58 Million | -81.94 Million |
| Earnings Per Share Basic | 0.18 | 1.25 | -0.39 | 0.53 | -0.01 | -0.15 |
| Earnings Per Share Diluted | 0.17 | 1.25 | -0.39 | 0.52 | -0.01 | -0.15 |
| Weighted Average Shares Outstanding | 702.2 Million | 675.15 Million | 674.13 Million | 662.28 Million | 596.56 Million | 552.74 Million |
| Weighted Average Shares Outstanding (Diluted) | 704.53 Million | 677.07 Million | 674.13 Million | 666.32 Million | 596.56 Million | 552.74 Million |
| Gross Margin | 0.22 | 0.22 | 0.20 | 0.23 | 0.23 | 0.26 |
| EBIT Margin | 0.03 | 0.04 | -0.04 | 0.02 | 0.00 | -0.01 |
| Profit Margin | 0.03 | 0.03 | -0.01 | 0.02 | -0.00 | -0.02 |
| EBITDA | 926.08 Million | 999.05 Million | -188.12 Million | 305.8 Million | 9.16 Million | -58.96 Million |
| Earnings Before Tax Margin | 0.03 | 0.03 | -0.04 | 0.02 | -0.00 | -0.01 |
| Breakdown | 2024 Q4 | 2024 FY | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 1.95 Billion | 27.02 Billion | 1.81 Billion | 26.76 Billion | 2.18 Billion | 1.7 Billion |
| Cost of Revenue | 1.53 Billion | 21.13 Billion | 1.41 Billion | 21.06 Billion | 1.69 Billion | 1.36 Billion |
| Gross Profit | 419.86 Million | 5.89 Billion | 402.09 Million | 5.7 Billion | 487.26 Million | 341.6 Million |
| Operating Expenses | 368.05 Million | 5.17 Billion | 365.43 Million | 5.73 Billion | 489.36 Million | 346.12 Million |
| Selling, General and Administrative Expenses | 314.49 Million | - | 320.67 Million | - | 438.66 Million | 298.01 Million |
| Research and Development Expenses | 53.55 Million | - | 44.75 Million | - | 50.69 Million | 48.1 Million |
| Other Expenses | - | -359.36 Million | - | 577.23 Million | - | - |
| Cost and Expenses | 1.9 Billion | 26.3 Billion | 1.77 Billion | 26.79 Billion | 2.18 Billion | 1.71 Billion |
| Operating Income | 51.81 Million | 872.4 Million | 36.66 Million | 493.1 Million | -2.1 Million | -4.51 Million |
| Interest Expense | 487.75 Thousand | 5.96 Million | 343.82 Thousand | 5.83 Million | 354.05 Thousand | 499.19 Thousand |
| Income Tax Expense | 2.79 Million | 56.26 Million | 5.06 Million | 16.73 Million | 678.01 Thousand | 1.78 Million |
| Earnings before Tax | 63.23 Million | 939.39 Million | 68.6 Million | 550.99 Million | 52.44 Million | 25.77 Million |
| Net Income | 60.7 Million | 883.47 Million | 62.49 Million | 535.65 Million | 53.4 Million | 23.85 Million |
| Earnings Per Share Basic | 0.08 | - | 0.09 | - | 0.08 | 0.04 |
| Earnings Per Share Diluted | 0.08 | - | 0.09 | - | 0.08 | 0.04 |
| Weighted Average Shares Outstanding | 731.5 Million | 702.2 Million | 675.64 Million | 675.15 Million | 675.04 Million | 675.44 Million |
| Weighted Average Shares Outstanding (Diluted) | 734.27 Million | 704.53 Million | 677.6 Million | 677.07 Million | 675.04 Million | 676.05 Million |
| Gross Margin | 0.22 | 0.22 | 0.22 | 0.21 | 0.22 | 0.20 |
| EBIT Margin | 0.03 | - | 0.02 | - | 0.00 | 0.00 |
| Profit Margin | 0.03 | 0.03 | 0.03 | 0.02 | 0.02 | 0.01 |
| EBITDA | 55.75 Million | - | 40.19 Million | - | 1.88 Million | 810.26 Thousand |
| Earnings Before Tax Margin | 0.03 | 0.03 | 0.02 | 0.02 | -0.00 | -0.00 |
OPXS
PCR
GAM
IMS
300632
MKPL